Bayer Adalat (cardiovascular)
GPTKB entity
Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:nifedipine
|
| gptkbp:ATCCode |
gptkb:C08CA05
|
| gptkbp:brand |
gptkb:nifedipine
|
| gptkbp:contraindication |
pregnancy (certain forms)
severe aortic stenosis unstable angina |
| gptkbp:drugClass |
gptkb:beta_blocker
|
| gptkbp:form |
gptkb:tablet
capsule |
| gptkbp:indication |
hypertension
angina pectoris |
| gptkbp:manufacturer |
gptkb:Bayer
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
edema
dizziness headache flushing |
| gptkbp:therapeuticArea |
cardiovascular diseases
|
| gptkbp:bfsParent |
gptkb:Bayer
|
| gptkbp:bfsLayer |
5
|
| https://www.w3.org/2000/01/rdf-schema#label |
Bayer Adalat (cardiovascular)
|